市場調査レポート

商品コード

1510396

医用イメージング試薬の市場規模、シェア、成長分析：クラス別、技術別、用途別、地域別 - 産業予測、2024-2031年

Medical Imaging Reagents Market Size, Share, Growth Analysis, By Class, By Technology, By Region - Industry Forecast 2024-2031

出版日: 2024年07月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医用イメージング試薬市場規模は2022年に195億5,000万米ドルと評価され、予測期間（2024-2031年）のCAGRは9.20%で、2023年の213億5,000万米ドルから2031年には431億7,000万米ドルに成長する見通しです。

医用イメージング試薬市場はヘルスケア部門の重要な構成要素であり、診断や研究に不可欠なツールを提供しています。これらの試薬は、MRI、CT、超音波、核医学などのイメージング技術において、組織や臓器の可視性を高めます。主な市場促進要因としては、慢性疾患率の上昇、高齢化、早期かつ正確な診断の必要性などが挙げられます。解剖学的詳細とともに機能的・代謝的洞察を提供する分子イメージングへのシフトは、個別化治療のために特定の分子を標的とする高度な試薬への需要を高めています。PET/CTやSPECT/CTのようなハイブリッドイメージングシステムは、複数のプラットフォームに対応する汎用性の高い試薬の必要性を煽っています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

GE Healthcare（USA）
Siemens Healthineers（Germany）
Thermo Fisher Scientific（USA）
Bayer AG（Germany）
Bracco Imaging S.p.A.（Italy）
Lantheus Medical Imaging（USA）
Mallinckrodt Pharmaceuticals（USA）
Koninklijke Philips N.V.（Netherlands）
Fujifilm Holdings Corporation（Japan）
PerkinElmer（USA）
Hologic, Inc.（USA）
EliTechGroup（France）
Curium Pharma（France）
NanoScan Imaging（USA）
Eisai Co., Ltd.（Japan）
J.B. Chemicals & Pharmaceuticals Ltd.（India）
Nordion Inc.（Canada）
Jubilant Life Sciences Ltd.（India）
Astellas Pharma, Inc.（Japan）
Cyclopharm Ltd.（Australia）
Cardinal Health, Inc.（USA）
Life Molecular Imaging（Germany）
AdvaCare Pharma（USA）
The Medical House PLC（UK）
Lumiphore, Inc.（USA）

Product Code: SQMIG35A2744

Medical Imaging Reagents Market size was valued at USD 19.55 Billion in 2022 and is poised to grow from USD 21.35 Billion in 2023 to USD 43.17 Billion by 2031, at a CAGR of 9.20% during the forecast period (2024-2031).

The Medical Imaging Reagents Market is an essential component of the healthcare sector, providing critical tools for diagnostics and research. These reagents enhance tissue and organ visibility in imaging techniques like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include rising chronic disease rates, an ageing population, and the need for early, accurate diagnoses. The shift towards molecular imaging, offering functional and metabolic insights along with anatomical details, has increased the demand for advanced reagents that target specific molecules for personalized treatment. Ongoing R&D efforts focus on developing safer, more efficient reagents, while hybrid imaging systems like PET/CT and SPECT/CT fuel the need for versatile reagents compatible with multiple platforms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segmental Analysis

The global medical imaging reagents market is segmented on the basis of class, technology, application and region. By class, the market is segmented into Contrast Reagents, Optical Reagents, and Nuclear Reagents. By technology, the market is segmented into Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots. By application, the market is segmented into Diagnostics, Drug Discovery & Development, Educational Research. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Medical Imaging Reagents Market

The rising incidence of chronic diseases like cancer, cardiovascular disorders, and neurological conditions has significantly boosted the need for advanced medical imaging procedures. This surge in demand underscores the critical role of medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. As these reagents improve the clarity and detail of imaging results, they become indispensable in accurately diagnosing and monitoring these complex diseases, thereby driving their widespread use in the medical field. This trend highlights the vital importance of innovation and accessibility in medical imaging technologies to meet the growing healthcare challenges.

Restraints in the Medical Imaging Reagents Market

Medical imaging reagents, particularly those utilized in advanced imaging modalities such as PET and MRI, often come with high costs. The expenses associated with these reagents, along with the sophisticated equipment and related healthcare services, pose a substantial financial challenge for both healthcare facilities and patients. This economic barrier can hinder the market's expansion, especially in regions with lower income levels, where the financial strain is more pronounced. Consequently, the high costs can restrict access to these advanced imaging techniques, potentially impacting the quality of healthcare and diagnostic capabilities in economically disadvantaged areas.

Market Trends of the Medical Imaging Reagents Market

The demand for molecular imaging reagents, particularly PET and SPECT radiopharmaceuticals, has been on the rise due to their critical role in visualizing and quantifying biological processes at the molecular and cellular levels. This capability is essential for early disease detection, precise treatment planning, and ongoing monitoring. The trend is fueled by advancements in radiopharmaceutical development, which have led to the creation of more targeted and specific imaging agents, enhancing their effectiveness and precision in medical diagnostics and research. These innovations are revolutionizing the field, making molecular imaging an indispensable tool in modern healthcare.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Medical Imaging Reagents Market by Class

Market Overview
Contrast Reagents
Optical Reagents
Nuclear Reagents

Medical Imaging Reagents Market by Technology

Market Overview
Nanoparticles
Fluorescent Dyes & Probes
Radiopharmaceuticals
Fluorescent Proteins
Quantum Dots

Medical Imaging Reagents Market by Application

Market Overview
Dignostic
Drug discovery & Technology
Educational Research

Medical Imaging Reagents Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EliTechGroup (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoScan Imaging (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eisai Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J.B. Chemicals & Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyclopharm Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Life Molecular Imaging (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Medical House PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lumiphore, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

医用イメージング試薬の市場規模、シェア、成長分析：クラス別、技術別、用途別、地域別 - 産業予測、2024-2031年

Medical Imaging Reagents Market Size, Share, Growth Analysis, By Class, By Technology, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

医用イメージング試薬市場：クラス別

医用イメージング試薬市場：技術別

医用イメージング試薬市場：用途別

医用イメージング試薬市場：地域別